These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34146428)

  • 1. Neurotoxicity associated with acyclovir and valacyclovir: A systematic review of cases.
    Brandariz-Nuñez D; Correas-Sanahuja M; Maya-Gallego S; Martín Herranz I
    J Clin Pharm Ther; 2021 Aug; 46(4):918-926. PubMed ID: 34146428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aciclovir and valaciclovir neurotoxicity in patients with renal failure.
    Almond MK
    Nephrol Dial Transplant; 2003 Dec; 18(12):2680; author reply 2680-1. PubMed ID: 14605302
    [No Abstract]   [Full Text] [Related]  

  • 3. Valacyclovir-induced Neurotoxicity in a Patient with a Preserved Renal Function.
    Yoshimura T; Kawasaki T; Shirota A; Saeki M; Okada Y; Okada H
    Intern Med; 2018 Nov; 57(21):3213-3216. PubMed ID: 29877263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valacyclovir-associated neurotoxicity in peritoneal dialysis patients.
    Chaudhari D; Ginn D
    Am J Ther; 2014; 21(6):e215-7. PubMed ID: 23528373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valacyclovir neurotoxicity in a patient with end-stage renal disease treated with continuous ambulatory peritoneal dialysis.
    Okada T; Nakao T; Matsumoto H; Nagaoka Y; Iwasawa H; Nanri K; Yamazaki T
    Clin Nephrol; 2002 Aug; 58(2):168-70. PubMed ID: 12227692
    [No Abstract]   [Full Text] [Related]  

  • 6. Valacyclovir and Acyclovir Neurotoxicity With Status Epilepticus.
    Hoskote SS; Annapureddy N; Ramesh AK; Rose K; Jones JP
    Am J Ther; 2016; 23(1):e304-6. PubMed ID: 24368610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valacyclovir neurotoxicity: clinical experience and review of the literature.
    Asahi T; Tsutsui M; Wakasugi M; Tange D; Takahashi C; Tokui K; Okazawa S; Okudera H
    Eur J Neurol; 2009 Apr; 16(4):457-60. PubMed ID: 19187258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valacyclovir-associated neurotoxicity treated with intensification of peritoneal dialysis.
    Prasad B; McIsaac M; Toppings J
    BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28765478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neurologic toxicity caused by zelitrex (valaciclovir) in 3 patients with renal failure. Is overdose associated with improvement of product bioavailability improvement?].
    Peyrière H; Branger B; Bengler C; Vécina F; Pinzani V; Hillaire-Buys D; Blayac JP
    Rev Med Interne; 2001 Mar; 22(3):297-303. PubMed ID: 11270274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A case of acyclovir neurotoxicity presenting with atypical cerebrospinal fluid findings.
    Thind GS; Roach R
    BMJ Case Rep; 2017 May; 2017():. PubMed ID: 28536235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acyclovir-induced neurotoxicity and acute kidney injury in an elderly diabetic patient treated with valacyclovir: report of a case].
    Sagawa N; Tsurutani Y; Nomura K; Okuyama T; Kondo M; Sata A; Miyao M; Mizuno Y
    Nihon Ronen Igakkai Zasshi; 2014; 51(6):581-5. PubMed ID: 25749332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Encephalopathy and acute renal failure during acyclovir treatment].
    Delluc A; Mocquard Y; Latour P; Goas JY
    Rev Neurol (Paris); 2004 Jul; 160(6-7):704-6. PubMed ID: 15247861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acyclovir-Induced Neurotoxicity: A Case Report and Review of Literature.
    Chowdhury MA; Derar N; Hasan S; Hinch B; Ratnam S; Assaly R
    Am J Ther; 2016; 23(3):e941-3. PubMed ID: 24942005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Valacyclovir neurotoxicity can be effectively managed by hemodialysis.
    Kambhampati G; Pakkivenkata U; Kazory A
    Eur J Neurol; 2011 Mar; 18(3):e33. PubMed ID: 21087359
    [No Abstract]   [Full Text] [Related]  

  • 15. [Neurotoxicity of valacyclovir in a peritoneal dialysis patient].
    Takayanagi A; Maehana T; Kyoda Y; Yanase M
    Hinyokika Kiyo; 2010 Nov; 56(11):617-9. PubMed ID: 21187705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurotoxicity of acyclovir and valacyclovir in a hemodialyzed patient.
    Strumia S; De Mitri P; Bionda E
    Eur J Neurol; 2004 Jan; 11(1):68-9. PubMed ID: 14692893
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiviral agents for infectious mononucleosis (glandular fever).
    De Paor M; O'Brien K; Fahey T; Smith SM
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD011487. PubMed ID: 27933614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotoxicity secondary to valacyclovir.
    Rosales-Castillo A; López-González Gila JD; Clavero García E
    Med Clin (Barc); 2021 Apr; 156(7):361-362. PubMed ID: 32115197
    [No Abstract]   [Full Text] [Related]  

  • 19. A Case Report of Neurotoxicity After Prolonged Doses of Acyclovir in a Patient With Renal Dysfunction.
    Umoru GO; Shah PJ; Tariq F
    J Pharm Pract; 2020 Apr; 33(2):217-221. PubMed ID: 30669921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resolution of acyclovir-associated neurotoxicity with the aid of improved clearance estimates using a Bayesian approach: A case report and review of the literature.
    Watson WA; Rhodes NJ; Echenique IA; Angarone MP; Scheetz MH
    J Clin Pharm Ther; 2017 Jun; 42(3):350-355. PubMed ID: 28370067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.